The structure and reactivity of arsenic compounds: Biological activity and drug design-Reference-Cited by-同舟云学术

The structure and reactivity of arsenic compounds: Biological activity and drug design

Published:1991 Issue: Volume: Page:129-190
ISSN:0081-5993
Container-title:Structure and Bonding
language:
Short-container-title:

Author:

Ni Dhubhghaill Orla M.,Sadler Peter J.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/3-540-54261-2_3.pdf

Reference281 articles.

1. Polson CJ, Green MA, Lee MR (1983) Clinical Toxicology, 3rd edn, Pitman, London, chap 23, p 421

2. Schroeder HA, Balassa JJ (1966) Journal of Chronic Diseases 19: 85 and references cited therein

3. Doak GO, Freedman LD in: Medicinal Chemistry (ed A Burger), 2nd edn, Interscience, New York 1960, chap 47, pp 1027–1049 and references cited therein

4. Vallee BL: AMA Archives of Industrial Health 21, 132 (1960) and references cited therein

5. Squibb KS, Fowler BA (1983) In: Fowler BA(ed) Biological and environmental effects of arsenic, Elsevier, Amsterdam, chap 7, p 233 and references cited therein

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harness arsenic in medicine: current status of arsenicals and recent advances in drug delivery;Expert Opinion on Drug Delivery;2024-06-02

2. Construction of arsenic-metal complexes loaded nanodrugs for solid tumor therapy: A mini review;International Journal of Pharmaceutics;2020-06

3. New Sulfur-Containing Polyarsenicals from the New Caledonian Sponge Echinochalina bargibanti;Marine Drugs;2018-10-11

4. Probabilistic Risk Assessment of Inorganic Arsenic via Consumption of Herbs Collected in Thailand;Evidence-Based Complementary and Alternative Medicine;2018-07-15

5. Multivalency in the Inhibition of Oxidative Protein Folding by Arsenic(III) Species;Biochemistry;2014-12-30